These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 1601035)

  • 41. Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis.
    Ren Y; Savill J
    J Immunol; 1995 Mar; 154(5):2366-74. PubMed ID: 7532668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity.
    Ho JL; He SH; Rios MJ; Wick EA
    J Infect Dis; 1992 Feb; 165(2):344-51. PubMed ID: 1309848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Granulocyte-macrophage colony stimulating factor modulates the production of TNF alpha by differentiated U937 cells infected with Leishmania major.
    Arena A; Capozza AB; Marino F; Zummo S; Iannello D; Mastroeni P
    New Microbiol; 1999 Jan; 22(1):31-9. PubMed ID: 10190115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinct in vivo functions of two macrophage subpopulations as evidenced by studies using macrophage-deficient op/op mouse.
    Wiktor-Jedrzejczak W; Ansari AA; Szperl M; Urbanowska E
    Eur J Immunol; 1992 Jul; 22(7):1951-4. PubMed ID: 1378025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.
    Ikeda-Dantsuji Y; Ohno H; Tanabe K; Umeyama T; Ueno K; Nagi M; Yamagoe S; Kinjo Y; Miyazaki Y
    J Infect Chemother; 2015 Dec; 21(12):831-6. PubMed ID: 26477011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of Trypanosoma brucei gambiense and Trypanosoma brucei brucei on rat macrophages.
    Nishimura K; Nakaya H; Nakagawa H; Matsuo S; Ohnishi Y; Yamasaki S
    J Parasitol; 2011 Feb; 97(1):48-54. PubMed ID: 21348606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production.
    Smith ME; van der Maesen K; Somera FP
    J Neurosci Res; 1998 Oct; 54(1):68-78. PubMed ID: 9778151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN-gamma and its protective effect against cryptococcal infection.
    Kawakami K; Kohno S; Kadota J; Tohyama M; Teruya K; Kudeken N; Saito A; Hara K
    Microbiol Immunol; 1995; 39(2):135-43. PubMed ID: 7783686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria.
    Riopel J; Tam M; Mohan K; Marino MW; Stevenson MM
    Infect Immun; 2001 Jan; 69(1):129-36. PubMed ID: 11119498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Capsular specific IgM enhances complement-mediated phagocytosis and killing of Cryptococcus neoformans by methamphetamine-treated J774.16 macrophage-like cells.
    Aslanyan L; Ekhar VV; DeLeon-Rodriguez CM; Martinez LR
    Int Immunopharmacol; 2017 Aug; 49():77-84. PubMed ID: 28551495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between granulocyte macrophage-colony stimulating factor, tumour necrosis factor-alpha and Trypanosoma cruzi infection of murine macrophages.
    Olivares Fontt E; Vray B
    Parasite Immunol; 1995 Mar; 17(3):135-41. PubMed ID: 7792097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential immunocompetence of macrophages derived using macrophage or granulocyte-macrophage colony-stimulating factor.
    Rutherford MS; Schook LB
    J Leukoc Biol; 1992 Jan; 51(1):69-76. PubMed ID: 1740646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of cytokines, platelet activating factor, and arachidonate metabolites on C3b receptor (CR1, CD35) expression and phagocytosis by neutrophils.
    Ogle JD; Noel JG; Sramkoski RM; Ogle CK; Alexander JW
    Cytokine; 1990 Nov; 2(6):447-55. PubMed ID: 1716488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.
    Rachini A; Pietrella D; Lupo P; Torosantucci A; Chiani P; Bromuro C; Proietti C; Bistoni F; Cassone A; Vecchiarelli A
    Infect Immun; 2007 Nov; 75(11):5085-94. PubMed ID: 17606600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection.
    Vecchiarelli A; Dottorini M; Pietrella D; Monari C; Retini C; Todisco T; Bistoni F
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):130-7. PubMed ID: 8049074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
    Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
    Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Granulocyte-macrophage colony-stimulating factor (GM-CSF) regulates cytokine induction by 1,3-beta-D-glucan SCG in DBA/2 mice in vitro.
    Harada T; Miura NN; Adachi Y; Nakajima M; Yadomae T; Ohno N
    J Interferon Cytokine Res; 2004 Aug; 24(8):478-89. PubMed ID: 15320961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of the capsule in microglial cell-Cryptococcus neoformans interaction: impairment of antifungal activity but not of secretory functions.
    Barluzzi R; Brozzetti A; Delfino D; Bistoni F; Blasi E
    Med Mycol; 1998 Aug; 36(4):189-97. PubMed ID: 9776834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.
    Denis M
    J Leukoc Biol; 1991 Apr; 49(4):380-7. PubMed ID: 1900522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
    Chiller T; Farrokhshad K; Brummer E; Stevens DA
    Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.